Stockreport

Revolution Medicines stock surges over 20% on potential AbbVie acquisition [Yahoo! Finance]

Revolution Medicines, Inc.  (RVMD) 
PDF Journal report that AbbVie (NYSE:ABBV) is in advanced talks to acquire the clinical-stage precision oncology company. According to people familiar with the matter, Abb [Read more]